Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -73.22% is 87% above its 5-year average of -562.44%, near the high end of its 5-year range (-43373.64%–2662.84%).
99.39% above its 12-month average of -11947.63%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -3849.90%.
NET PROFIT MARGIN
-73.22%
NET PROFIT MARGIN AVG TTM
-11947.63%
NET PROFIT MARGIN AVG 3Y
-810.21%
NET PROFIT MARGIN AVG 5Y
-562.44%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+99.39%
CURRENT VS 3Y AVG
+90.96%
CURRENT VS 5Y AVG
+86.98%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 631 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
HCW Biologics Inc.
Market Cap
$560606.00
Net Profit Margin
-73.22%
TTM Avg
-11947.63%
3Y Avg
-810.21%
5Y Avg
-562.44%
Market Cap
$669300.00
Net Profit Margin
6.30%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$375425.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-352.76%
5Y Avg
-376.69%
Market Cap
$820528.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-933.28%
5Y Avg
-622.19%
Market Cap
$835190.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-23.42%
Market Cap
$865985.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$870069.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.02M
Net Profit Margin
-11314.24%
TTM Avg
-197362.53%
3Y Avg
-98681.26%
5Y Avg
-78945.01%
Market Cap
$62143.00
Net Profit Margin
-17690.19%
TTM Avg
-9089.88%
3Y Avg
-5029.73%
5Y Avg
-25219.12%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HCW Biologics Inc. (HCWB) | $560606.00 | -73.22% | -11947.63% | -810.21% | -562.44% |
| CDT Equity Inc. (CDT)vs › | $669300.00 | 6.30% | 0.00% | 0.00% | 0.00% |
| Niki BioSolutions, Inc. (NIKI)vs › | $375425.00 | 0.00% | 0.00% | -352.76% | -376.69% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $820528.00 | 0.00% | 0.00% | -933.28% | -622.19% |
| Decoy Therapeutics Inc. (DCOY)vs › | $835190.00 | 0.00% | 0.00% | 0.00% | -23.42% |
| GlucoTrack, Inc. (GCTK)vs › | $865985.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Bone Biologics Corporation (BBLG)vs › | $870069.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | -11314.24% | -197362.53% | -98681.26% | -78945.01% |
| Akanda Corp. (AKAN)vs › | $62143.00 | -17690.19% | -9089.88% | -5029.73% | -25219.12% |
| Clearmind Medicine Inc. (CMND)vs › | $1.08M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-20757.7%
Net Profit Margin
-73.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -3849.90% |
| 2026-03-31 | 63.16% |
| 2025-12-31 | 2662.84% |
| 2025-09-30 | -29183.24% |
| 2025-06-30 | -29430.99% |
| 2025-03-31 | -43373.64% |
| 2024-12-31 | -854.42% |
| 2024-09-30 | -915.12% |
| 2024-06-30 | -2469.11% |
| 2024-03-31 | -662.82% |
| 2023-12-31 | -806.69% |
| 2023-09-30 | -578.90% |
| 2023-06-30 | -691.13% |
| 2023-03-31 | -12106.79% |
| 2022-12-31 | -403.93% |
| 2022-09-30 | -216.37% |
| 2022-06-30 | -773.14% |
| 2022-03-31 | -65.99% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 50.27% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
